Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02027532 · ClinicalTrials.gov registry record · NA
Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin
A NA study, sponsored by University of Tennessee.
- Terminated
- Registry status
- NA
- Development phase
- 430
- Enrollment target
NCT02027532 is a NA study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 430 participants.
The verdict
NCT02027532, a NA study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- NA
- Development phase
- 430 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period. The hypothesis of this study is that patients undergoing surgical treatment for closed fractures who are treated prophylactically with Vancomycin will have a lower incidence rate of infection than patients who are treated prophylactically with Cefazolin.
Interventions
- DRUG Vancomycin
- DRUG Cefazolin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430 participants |
| Start Date | 2009-10 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02027532
The ClinicalTrials.gov registry entry for NCT02027532 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 430 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vancomycin is the first listed.
NCT02027532 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02027532 about?
NCT02027532 is a clinical study titled "Prevention of Infection in Closed Fractures: Cefazolin Versus Vancomycin". The purpose of this study is to compare the incidence rate of infection in surgical patients with closed fractures treated prophylactically with Cefazolin versus Vancomycin in the peri-operative period. The hypothesis of this study is that patients undergoing surgical treatment for closed fractures...
What is the current status of trial NCT02027532?
This trial is currently terminated. It is a NA study. The enrollment target is 430 participants. The study started on 2009-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02027532?
The interventions under investigation include: Vancomycin (DRUG), Cefazolin (DRUG).
Who is sponsoring clinical trial NCT02027532?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.